2007-01-05T00:00:00
Researchers from the Royal Marsden Hospital in London have confirmed that giving Herceptin to women with certain types of breast cancer does prolong their lives. The study, published in The Lancet, followed women for two years after treatment and found a 2.7 per cent ...
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud